Clinical trial
Prospective, Randomized Controlled Trial Comparing Analgesic Efficacy of Single Injection vs. Continuous Interscalene Blockade vs. Local Infiltration Analgesia for Patients Undergoing Primary Total Shoulder Arthroplasty
NCT02876055 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized Controlled Trial Comparing Analgesic Efficacy of Single Injection vs. Continuous Interscalene Blockade vs. Local Infiltration Analgesia for Patients Undergoing Primary Total Shoulder Arthroplasty
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- February 28, 2018
- Enrollment
- 125 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative